Cargando…
Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251815/ https://www.ncbi.nlm.nih.gov/pubmed/30505664 http://dx.doi.org/10.1016/j.apsb.2018.07.012 |
_version_ | 1783373149497196544 |
---|---|
author | Liu, Ergang Zhang, Meng Cui, Hui Gong, Junbo Huang, Yongzhuo Wang, Jianxin Cui, Yanna Dong, Weibing Sun, Lu He, Huining Yang, Victor C. |
author_facet | Liu, Ergang Zhang, Meng Cui, Hui Gong, Junbo Huang, Yongzhuo Wang, Jianxin Cui, Yanna Dong, Weibing Sun, Lu He, Huining Yang, Victor C. |
author_sort | Liu, Ergang |
collection | PubMed |
description | In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC(50) of Tat-FeAgNP-Dox to be 0.63 µmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% (P = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles. |
format | Online Article Text |
id | pubmed-6251815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-62518152018-11-30 Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery Liu, Ergang Zhang, Meng Cui, Hui Gong, Junbo Huang, Yongzhuo Wang, Jianxin Cui, Yanna Dong, Weibing Sun, Lu He, Huining Yang, Victor C. Acta Pharm Sin B Original article In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe(3)O(4) nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC(50) of Tat-FeAgNP-Dox to be 0.63 µmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% (P = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles. Elsevier 2018-10 2018-08-06 /pmc/articles/PMC6251815/ /pubmed/30505664 http://dx.doi.org/10.1016/j.apsb.2018.07.012 Text en © 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original article Liu, Ergang Zhang, Meng Cui, Hui Gong, Junbo Huang, Yongzhuo Wang, Jianxin Cui, Yanna Dong, Weibing Sun, Lu He, Huining Yang, Victor C. Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title | Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title_full | Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title_fullStr | Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title_full_unstemmed | Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title_short | Tat-functionalized Ag-Fe(3)O(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
title_sort | tat-functionalized ag-fe(3)o(4) nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251815/ https://www.ncbi.nlm.nih.gov/pubmed/30505664 http://dx.doi.org/10.1016/j.apsb.2018.07.012 |
work_keys_str_mv | AT liuergang tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT zhangmeng tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT cuihui tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT gongjunbo tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT huangyongzhuo tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT wangjianxin tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT cuiyanna tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT dongweibing tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT sunlu tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT hehuining tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery AT yangvictorc tatfunctionalizedagfe3o4nanocompositesastissuepenetratingvehiclesfortumormagnetictargetinganddrugdelivery |